✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Supha Pharmachem Ltd.

REMLIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹76 Cr.
P/E
35.62

Supha Pharmachem Ltd.

  • Supha Pharmachem
  • Yuvraaj Hygiene Prod
  • Future Consumer

FAQs on Supha Pharmachem Ltd. Shareprice

Supha Pharmachem has given better returns compared to its competitors.
Supha Pharmachem has grown at ~36.64% over the last 6yrs while peers have grown at a median rate of 28.87%

Supha Pharmachem is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Supha Pharmachem is 35.62, while 3 year average PE is 57.01.
Also latest EV/EBITDA of Supha Pharmachem is 351 while 3yr average is 236.

View FAQ's On Business

Growth Table

  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Balance Sheet

  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Cash Flow

  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Quarterly Results

  • Supha Pharmachem Ltd.
  • Yuvraaj Hygiene Prod
  • Future Consumer

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Supha Pharmachem Ltd. Financials

Supha Pharmachem balance sheet is weak and might have solvency issues

The net debt of Supha Pharmachem is decreasing.
Latest net debt of Supha Pharmachem is ₹1,086 Crs as of Sep-25.
This is less than Mar-25 when it was ₹1,139 Crs.

The profit is oscillating.
The profit of Supha Pharmachem is ₹11.22 Crs for TTM, ₹2.13 Crs for Mar 2025 and ₹32.73 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Supha Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech